MSOP GP, L.L.C.
CIK
1672666
Location
MENLO PARK, CA
Portfolio Value
Small
$439,261,555
Diversification
Highly concentrated
Filing Date
Dec 31, 2025
Global Rank
#2,868
/ 8,664
· as of Dec 2025
Top Industry
Software - Application
100.0%
3Y Alpha vs SPY
-10.5%
Period ended 6 months ago
Filed Feb 17, 2026 · 5mo
Clone Performance
Feb 2026–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+6.6%
SPY
+9.6%
Annualised alpha
-8.7%
Max drawdown
−32.6%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
3 positions · as of Dec 31, 2025Top Position
99.9%
of portfolio value
Top 5
100.0%
of portfolio value
Top 10
100.0%
of portfolio value
HHI
9,990
Highly concentrated
Sector Breakdown
As of Dec 31, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Technology | 100.0% | $439,224,389 |
| Healthcare | 0.0% | $37,166 |
3 positions ·
$439,261,555 total
· as of Dec 31, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CHYM |
Chime Financial, Inc.
Technology
|
First | 17,442,713 | $439,033,086 | 99.95% | |
| BRZE |
Braze, Inc.
Technology
|
First | 5,579 | $191,303 | 0.04% | |
| SNTI |
Senti Biosciences Holdings, Inc.
Healthcare
|
First | 35,737 | $37,166 | 0.01% |